Skip to content
OpenCapital
Get started

Geron GERN Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
Incyte logo
IncyteINCY
$18.73B+59.9%
Immunome logo
ImmunomeIMNM
$2.47B+323%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$2.06B+95.0%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$2.71B+226%
Celcuity logo
CelcuityCELC
$5.52B+1,370%

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Enterprise value$973.78M-5.3%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Computed from the period-end share price: $954.41M.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's market capitalization?
Geron (GERN) reported market capitalization of $954.41M in Q1 2026.
How has Geron's market capitalization changed year-over-year?
Geron's market capitalization decreased by 5.8% year-over-year, from $1.01B to $954.41M.
What is the long-term trend for Geron's market capitalization?
Over 5 years (2020 to 2025), Geron's market capitalization has grown at a 10.5% compound annual growth rate (CAGR), from $511.9M to $842.63M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.